Cargando…

Comorbidities and mortality rate in COVID‐19 patients with hematological malignancies: A systematic review and meta‐analysis

INTRODUCTION: The global pandemic of coronavirus disease 2019 (COVID‐19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). It seems that there is an association between blood cancer and an increased risk of severe COVID‐19. This study aimed to review the literature repor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naimi, Adel, Yashmi, Ilya, Jebeleh, Reza, Imani Mofrad, Mohammad, Azimian Abhar, Shakiba, Jannesar, Yasaman, Heidary, Mohsen, Pakzad, Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102765/ https://www.ncbi.nlm.nih.gov/pubmed/35385130 http://dx.doi.org/10.1002/jcla.24387

Ejemplares similares

Clinical manifestations, treatment options, and comorbidities in COVID‐19 relapse patients: A systematic review
por: Koupaei, Maryam, et al.
Publicado: (2022)

Clinical Characteristics, Diagnosis, Treatment, and Mortality Rate of TB/COVID-19 Coinfectetd Patients: A Systematic Review
por: Koupaei, Maryam, et al.
Publicado: (2021)

Mechanism of action, resistance, synergism, and clinical implications of azithromycin
por: Heidary, Mohsen, et al.
Publicado: (2022)

Antiviral effects of azithromycin: A narrative review
por: Khoshnood, Saeed, et al.
Publicado: (2022)

Prevalence, diagnosis, and manifestations of brucellosis: A systematic review and meta-analysis
por: Khoshnood, Saeed, et al.
Publicado: (2022)

The mortality burden of hematological malignancies in Ecuador
por: Garrido, David, et al.
Publicado: (2021)

Trends in mortality from infection among patients with hematologic malignancies: differences according to hematologic malignancy subtype
por: Yin, Xuejiao, et al.
Publicado: (2023)

Epidemiology and trend in skin cancer mortality in Iran
por: Pakzad, Reza, et al.
Publicado: (2015)

The incidence and mortality of prostate cancer and its relationship with development in Asia
por: Pakzad, Reza, et al.
Publicado: (2015)

Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies
por: Borah, Pronamee, et al.
Publicado: (2021)

COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality
por: Niu, Alex, et al.
Publicado: (2020)

Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies
por: Salih, Zena, et al.
Publicado: (2013)

CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
por: Marofi, Faroogh, et al.
Publicado: (2021)

Macrophage-Based Therapeutic Strategies in Hematologic Malignancies
por: Khalili, Saeed, et al.
Publicado: (2023)

Disseminated fusariosis with cutaneous involvement in hematologic malignancies: report of six cases with high mortality rate
por: Hayashida, Marina Zoéga, et al.
Publicado: (2018)

High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies()
por: Niu, Alex, et al.
Publicado: (2021)

The effect of theory-based educational intervention on correct principles of manual material handling among men
por: Mohammadian, Farough, et al.
Publicado: (2020)

Incidence and mortality of kidney cancer and its relationship with HDI (Human Development Index) in the world in 2012
por: MOHAMMADIAN, MARYAM, et al.
Publicado: (2017)

Carbamazepine and Hematological Malignancies
por: Yavaşoğlu, İrfan, et al.
Publicado: (2013)

Malignant benign hematology
por: Sholzberg, Michelle
Publicado: (2018)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

Deubiquitinases in hematological malignancies
por: Lei, Hu, et al.
Publicado: (2021)

Autophagy in Hematological Malignancies
por: García Ruiz, Olga, et al.
Publicado: (2022)

Intrarectal Lidocaine-Diltiazem-Meperidine Gel for Transrectal Ultrasound Guided Prostate Biopsy
por: Imani, Farsad, et al.
Publicado: (2015)

Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies
por: Testa, Ugo, et al.
Publicado: (2022)

Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
por: Găman, Amelia Maria
Publicado: (2023)

Molecular Epidemiology of Epstein-Barr virus (EBV) in Patients with Hematologic Malignancies
por: Tabibzadeh, Alireza, et al.
Publicado: (2020)

Socioeconomic inequality in self-rated health and its determinants: an Oaxaca blinder decomposition in Ilam, West of Iran during 2023
por: Bazyar, Mohammad, et al.
Publicado: (2023)

Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies—A prospective study
por: Chachaj, Angelika, et al.
Publicado: (2018)

Characteristics and predictors of mortality of patients with hematologic malignancies requiring invasive mechanical ventilation
por: Al-Dorzi, Hasan M., et al.
Publicado: (2017)

The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies
por: Çalık, Şebnem, et al.
Publicado: (2018)

Predictors of Early and Late Mortality for Patients with Hematologic Malignancy and Invasive Mold Disease
por: Yashphe, Eva L., et al.
Publicado: (2021)

Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020
por: Mangone, Lucia, et al.
Publicado: (2023)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

Chest multidetector computed tomography imaging of COVID-19 pneumonia patients with hematologic malignancies
por: El-Badrawy, Adel, et al.
Publicado: (2022)

Palpation by blind examiners: A novel approach for glaucoma screening
por: Heidary, Fatemeh, et al.
Publicado: (2010)

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009)

The treatment of hematologic malignancies in pregnancy
por: Vandenbriele, C., et al.
Publicado: (2010)

‘Leaky gut’ in hematological malignancies()
por: Costa-Lima, Carolina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_apheln6odnj9emqc9b65l7sa6q